Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00899990 · ClinicalTrials.gov registry record
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 908
- Enrollment target
NCT00899990: Completed study, sponsored by Children's Oncology Group.
NCT00899990 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 908 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00899990 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 908 participants
- Enrollment target
Study Summary
This research study is collecting and storing samples of tumor tissue, bone marrow, and blood from patients with Ewing sarcoma. Collecting and storing samples of tumor tissue, bone marrow, and blood from patients with cancer to test in the laboratory may help the study of cancer in the future.
Interventions
- OTHER Laboratory Biomarker Analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 908 participants |
| Start Date | 2008-02-04 |
| Est. Completion | 2023-09-30 |
What the finished NCT00899990 record still lists
NCT00899990 is an observational study that tracks outcomes without assigning an intervention. The registered 908 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Laboratory Biomarker Analysis is the first listed.
NCT00899990 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00899990 about?
NCT00899990 is a clinical study titled "Collecting and Storing Biological Samples From Patients With Ewing Sarcoma". This research study is collecting and storing samples of tumor tissue, bone marrow, and blood from patients with Ewing sarcoma. Collecting and storing samples of tumor tissue, bone marrow, and blood from patients with cancer to test in the laboratory may help the study of cancer in the future.
What is the current status of trial NCT00899990?
This trial is currently completed. The enrollment target is 908 participants. The study started on 2008-02-04. Estimated completion is 2023-09-30.
What interventions are being tested in trial NCT00899990?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER).
Who is sponsoring clinical trial NCT00899990?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05658497 · 908 participants
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
- NCT06216548 · 909 participants · NA
E-PRIME For Children With Medical Complexity
- NCT06131840 · 914 participants · Phase 1
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- NCT05769777 · 901 participants · Phase 2
Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI